Correlation Between Immutep and Elevation Oncology

Can any of the company-specific risk be diversified away by investing in both Immutep and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immutep Ltd ADR and Elevation Oncology, you can compare the effects of market volatilities on Immutep and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and Elevation Oncology.

Diversification Opportunities for Immutep and Elevation Oncology

0.56

Correlation Coefficient

Immutep  Elevation Oncology

Very weak diversification

The 3 months correlation between Immutep and Elevation is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Immutep i.e., Immutep and Elevation Oncology go up and down completely randomly.

Pair Corralation between Immutep and Elevation Oncology

Given the investment horizon of 90 days Immutep Ltd ADR is expected to generate 0.28 times more return on investment than Elevation Oncology. However, Immutep Ltd ADR is 3.62 times less risky than Elevation Oncology. It trades about -0.07 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.11 per unit of risk. If you would invest  208.00  in Immutep Ltd ADR on December 30, 2024 and sell it today you would lose (22.00) from holding Immutep Ltd ADR or give up 10.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Immutep Ltd ADR  vs.  Elevation Oncology

Immutep Ltd ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Elevation Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Immutep and Elevation Oncology

The main advantage of trading using opposite Immutep and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.

The idea behind Immutep Ltd ADR and Elevation Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .